Connect: New growth areas and a 6% dividend yield (BUY) | M.P. Evans: Four reasons to Buy M.P. Evans (BUY) | The Joy of Techs: finnCap tech Quarterly – analyst interview | PPHE*: Strong demand, rising prices and an expanding portfolio (CORP)| Gemfields: Q1 operating results (BUY)| Akers Biosciences*: PIFA Heparin/PF4 Rapid Assay approved by CFDA (CORP)| Wentworth Resources: Production and payment update (BUY)| Xaar: IMS (HOLD)| In
04 Nov 2015
Morning Note
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note
M.P. Evans Group PLC (MPE:LON), 857 | Intercede Group plc (IGP:LON), 106 | Gemfields Group Limited (GEM:LON), 11.6
- Published:
04 Nov 2015 -
Author:
Andrew Darley | Guy Hewett | Mark Paddon | Cavendish Research - Pages:
Connect: New growth areas and a 6% dividend yield (BUY) | M.P. Evans: Four reasons to Buy M.P. Evans (BUY) | The Joy of Techs: finnCap tech Quarterly – analyst interview | PPHE*: Strong demand, rising prices and an expanding portfolio (CORP)| Gemfields: Q1 operating results (BUY)| Akers Biosciences*: PIFA Heparin/PF4 Rapid Assay approved by CFDA (CORP)| Wentworth Resources: Production and payment update (BUY)| Xaar: IMS (HOLD)| In